MARt-Depression Trial

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

September 3, 2021

Study Completion Date

September 3, 2021

Conditions
Major Depressive Disorder
Interventions
DEVICE

Soterix Medical tDCS mini-Clinical Trials system (mini-CT)

Participants are provided with an activation code. This code will unlock a single session with the pre-set 30 minute duration and intensity (direct current 2mA, current density 0.80A/m2, with anode over the left and cathode over the right dorsolateral prefrontal cortex, respectively). Home-based tDCS will involve 30-min tDCS (3 days per week) for the first 3 months and once weekly for the subsequent 3 months.

BEHAVIORAL

Computerized CBT (cCBT)

Each tDCS session will be delivered in combination with a computerized CBT module and participants will progress through the computerized CBT course (Beacon Therapist-Assisted-Internet-Delivered CBT) over the 6 months of treatment at their own pace.

Trial Locations (1)

M6J 1H4

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT03564067 - MARt-Depression Trial | Biotech Hunter | Biotech Hunter